Cost-effectiveness of icosapent ethyl, evolocumab, alirocumab, ezetimibe, or fenofibrate in combination with dtatins compared to statin monotherapy - Michaeli, Daniel; Michaeli, Julia; Boch, Tobias; Michaeli, Christoph T. (Clinical drug investigation, 2022)
Gesehen am 24.10.2023